Science 2002-10-25

Reversal of bone loss in mice by nongenotropic signaling of sex steroids.

S Kousteni, J R Chen, T Bellido, L Han, A A Ali, C A O'Brien, L Plotkin, Q Fu, A T Mancino, Y Wen, A M Vertino, C C Powers, S A Stewart, R Ebert, A M Parfitt, R S Weinstein, R L Jilka, S C Manolagas

Index: Science 298 , 843-846, (2002)

Full Text: HTML

Abstract

We show that sex steroids protect the adult murine skeleton through a mechanism that is distinct from that used to preserve the mass and function of reproductive organs. The classical genotropic actions of sex steroid receptors are dispensable for their bone protective effects, but essential for their effects on reproductive tissues. A synthetic ligand (4-estren-3alpha,17beta-diol) that reproduces the nongenotropic effects of sex steroids, without affecting classical transcription, increases bone mass and strength in ovariectomized females above the level of the estrogen-replete state and is at least as effective as dihydrotestosterone in orchidectomized males, without affecting reproductive organs. Such ligands merit investigation as potential therapeutic alternatives to hormone replacement for osteoporosis in both women and men [corrected].


Related Compounds

Related Articles:

The nongenotropic synthetic ligand 4-estren-3alpha17beta-diol is a high-affinity genotropic androgen receptor agonist.

2005-03-01

[Mol. Pharmacol. 67 , 744-748, (2005)]

The synthetic estrogen 4-estren-3 alpha,17 beta-diol (estren) induces estrogen-like neuroprotection.

2005-01-01

[Neurobiol. Dis. 19 , 331-339, (2005)]

Estren promotes androgen phenotypes in primary lymphoid organs and submandibular glands.

2005-01-01

[BMC Immunol. 6 , 16, (2005)]

More Articles...